| 參考文獻 | 參考資料
Aebi, H. (1984). Catalase in vitro. Methods Enzymol. 105:121-126.
Battaglia, M., Gianfrani, C., Gregori, S. and Roncarolo, M. G. (2004). IL-10-producing T regulatory type 1 cells and oral tolerance. Ann. N. Y. Acad Sci. 1029:142-153.
Barlogie, B., Tricot, G. and Anaissie, E. (2001). Thalidomide in the management of multiple myeloma. Semin. Oncol. 28:577-582.
Berlett, B. S. and Stadtman, E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272: 20313-20316.
Byun, C. H., Koh, J. M., Kim, D. K., Park, S. I., Lee, K. U. and Kim, G. S. (2005). Alpha-lipoic acid inhibits TNF-alpha-induced apoptosis in human bone marrow stromal cells. J. Bone Miner Res. 20:1125-1135.
Claessens, Y. E. and Fontenay-Roupie, M. (2002). Physiopathology of myelodysplastic syndromes. Pathol. Biol. 50:261-267.
Cragg, G. M. and Newman, D. J. (2005). Plants as a source of anti-cancer agents. J. Ethnopharmacol. 100:72-79.
Cottliar, A. S., Noriega, M. F., Narbaitz, M. and Slavutsky, I. R. (2005). Molecular analysis of telomere length in follicular lymphomas. Its participation in tumor progression. Medicina (B. Aires). 65:143-146.
Curtin, J. F., Donovan, M. and Cotter, T. G. (2002). Regulation and measurement of oxidative stress in apoptosis. J. Immunol. Methods 265: 49-72.
Cutts, S. M., Nudelman, A., Rephaeli, A. and Phillips, D. R. (2005). The power and potential of doxorubicin-DNA adducts. IUBMB Life. 57:73-81.
De Keersmaecker K, Cools, J. (2006). Chronic myeloproliferative disorders: a tyrosine kinase tale. Leukemia ;20:200-205.
Deleonardi, G., Biondi, A., D'Aurelio, M., Pich, M. M., Stankov, K., Falasca, A.,
Fang, J. P., Xu, H. G., Huang, S. L., Chen, C. and Huang, K. (2006). Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine. Pediatr Hematol Oncol. 23:45-50.
Formiggini, G., Bovina, C., Romeo, G., Lenaz, G. (2004). Plasma membrane oxidoreductase activity in cultured cells in relation to mitochondrial function and oxidative stress. Biofactors. 20:251-258.
Dunphy, C. H. (2006). Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications. Arch. Pathol. Lab. Med. 130:483-520.
Ek, T., Pinkava, M. and Abrahamsson, J. (2005). Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies. J. Pediatr Hematol Oncol. 27:364-369.
Fleming, R. A. (1997) An overview of cyclophosphamide and ifosfamide pharmacology. Pharmacotherapy. 17:146S-154S.
Gerasimenko, J. V., Gerasimenko, O. V., Palejwala, A., Tepikin, A. V., Petersen, O. H. and Watson, A. J. (2002). Menadione-induced apoptosis: roles of cytosolic Ca2+ elevations and the mitochondrial permeability transition pore. J. Cell Sci. 115: 485-497.
Gerlier, D. and Thomasset, N. (1986) Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods. 94:57-63.
Habig, W. H. and Jakoby, W. B. (1981). Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77:398-405.
Haddy, T.B., Mosher, R. B., Nunez, S. B.and Reaman, G. H. (2006). Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatr Blood Cancer. 46:258-261.
Haris, H., (2003). Free Radicals in Biology and Medicine. 077-222
Hartwig, U. F., Keller, U., Huber, C.and Peschel, C. (2001) Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1beta antisense RNA. J. Interferon Cytokine Res. 21:851-860.
Hernandez-Rivera, E. G. (2005). Hematopoietic stem-cell transplantation in aplastic anemia. Rev. Invest Clin. 57:298-304.
Hicsonmez, G. (2006). The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leuk. Res. 30:60-68.
Hissin, P. J. and Hilf, R. (1976). A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214-226.
Ilaria, R. L. Jr. (2005). Pathobiology of lymphoid and myeloid blast crisis and management issues. Hematology Am. Soc. Hematol Educ. Program. 188-194.
Islam, M. N. and Iskander, M. N. (2004). Microtubulin binding sites as target for developing anticancer agents. Mini. Rev. Med. Chem. 4:1077-1104.
Jansen, C., Miaskowski, C., Dodd, M., Dowling, G. and Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncol. Nurs. Forum. 32:1151-1163.
Jaime-Perez, J. C., Ruiz-Arguelles, G. J. and Gomez-Almaguer, D. (2005). Haematopoietic stem cell transplantation to treat aplastic anaemia. Expert Opin. Biol. Ther. 5:617-626.
Jarskog, L. F., Selinger, E. S., Lieberman, J. A. and Gilmore, J. H. (2004). Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am. J. Psychiatry. 161: 109-115
Jordan, C. T., (2005). The potential of targeting malignant stem cells as a treatment for leukemia. Future Oncol. 1:205-207.
Kehrer, J. P. (2000). The Haber-Weiss reaction and mechanisms of toxicity. Toxicology.149: 43-50.
Kim, P. M., Deboni, U. and Wells, P. G. (1997). Peroxidase-dependent bioactivation and oxidation of DNA and protein in benzo [a] pyrene initiated micronucleus formation. Free Radic. Biol. Med. 23: 579-596.
Kim, D. J., Koh, J. M., Lee, O., Kim, N. J., Lee, Y. S., Kim, Y. S., Park, J. Y., Lee, K. U. and Kim, G. S. (2006). Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 07415: 388-397.
Kim, M. H., Chung, J., Yang, J. W., Chung, S. M., Kwag, N. H. and Yoo, J. S. (2003). Hydrogen peroxide-induced cell death in a human retinal pigment epithelial cell line, ARPE-19. Korean. J. Ophthalmol. 17: 19-28.
Klimm, B., Diehl, V. and Engert, A. (2005). Hodgkin's disease.Med Suisse. 1:2872-2877
Kuo, T. T., Shih, L. Y. and Tsang, N. M. (2004). Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int. J. Surg. Pathol. 12:375-387.
Lauta, V. M. (2003). A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97:2440-2452
Leon-Rodriguez, E. (2005). Hematopoietic stem cell transplantation in the myelodisplastic syndromes. Rev. Invest Clin. 57:283-290.
Li, J., Kleeff, J., Guo, J., Fischer, L., Giese, N., Buchler, M. W. and Friess, H. (2003). Effects of STI571 (gleevec) on pancreatic cancer cell growth. Mol. Cancer 2:32.
Lopez, E., Arce, C., Oset-Gasque, M. J., Canadas, S. and Gonzalez, M. P. (2006). Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic Biol. Med. 40:940-951.
Lowry, O. H., Rosebrugh, N. J., Farr, A. L. and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
Lund, F. E., Garvy, B. A., Randall, T. D. and Harris, D. P. (2005). Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8:25-54.
Lust, J. A. and Donovan, K. A. (1999). The role of interleukin-1 beta in the pathogenesis of multiple myeloma. Hematol Oncol. Clin. North Am. 13:1117-1125.
Marasca, R., Maffei, R., Zucchini, P., Castelli, I., Saviola, A., Martinelli, S., Ferrari, A., Fontana, M., Ravanetti, S. and Torelli, G. (2006). Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status. Leukemia. 20:103-114.
Martin, W. G., Ristow, K. M., Habermann, T. M., Colgan, J. P., Witzig, T. E. and Ansell, S. M. (2005). Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma. J. Clin. Oncol. 23:7614-7620.
McCord, J. M. and Fridovich, I. (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-6055.
Meyers, C. A., Albitar, M. and Estey, E. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.Cancer. 104:788-793.
Nelson, S. M., Ferguson, L. R. and Denny, W. A. (2004). DNA and the chromosome-varied targets for chemotherapy. Cell & Chromosome. Doi. : 10.1186/1475-9268-3-2
Nishimura, H. and Asahara, T. (2005). Bone marrow-derived endothelial progenitor cells for neovascular formation. EXS. 94:147-154.
Paglia, D. E. and Valentine, W. N. (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:158-169.
Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S., Kuppers, R. and Dalla-Favera, R. (2001). Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346.
Pourquier, P., Takebayashi, Y., Urasaki, Y., Gioffre, C., Kohlhagen, G. and Pommier, Y. (2000). Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (Ara-C) in vitro and in ara-C-treated cells. Proc. Natl. Acad. Sci. U S A. 97:1885-1890.
Sano, J., Nagafuchi, S., Yamazaki, J., Oguma, K., Kano, R. and Hasegawa, A. (2005). Effect of antineoplastic drugs on the expression of Bcl-2 and Bcl-xL genes in the feline T-cell leukemia cell line. Res. Vet. Sci. 79:197-201.
Schally, A. V. and Nagy, A. (2004). Chemotherapy targeted to cancers through tumoral hormone receptors. Trends Endocrinol Metab. 15:300-310.
Shaw, P. M., Reiss, A., Adesnik, M., Nebert, D. W., Schembri, J. and Jaiswal, A. K. (1991). The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. Eur. J. Biochem. 195:171-176.
Skladanowski, A., Come, M. G., Sabisz, M., Escargueil, A. E. and Larsen, A. K. (2005). Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents. Mol. Pharmacol. 68:625-634.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J. and Klenk, D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
Stoycheva, M. V. and Murdjeva, M. A. (2004). Cytokines in Salmonella infections. Folia. Med. (Plovdiv). 46:5-10.
Tada, M., Yokosuka, O., Fukai, K., Chiba, T., Imazeki, F., Tokuhisa, T. and Saisho, H. (2005). Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma. J. Hepatol. 42:511-519.
Takagi, M. (2005). Cell processing engineering for ex-vivo expansion of hematopoietic cells. J. Biosci. Bioeng. 99:189-196.
Traulle, C. and Coiffier, B. B. (2005). Evolving role of rituximab in the treatment of patients with non-Hodgkin's lymphoma. Future Oncol.1:297-306.
Toth, E., Schneider, T., Melegh, Z., Csernak, E., Udvarhelyi, N., Rosta, A. and Szentirmay, Z. (2005). Complex diagnosis of follicular lymphomas. Magy. Onkol. 49:135-140.
Yoneyama, A. (2005).Useful clinical tests for early diagnosis of hematologic disorders. Nippon Naika Gakkai Zasshi. 94:2530-2537.
Wetzler, M., Kurzrock, R., Lowe, D. G., Kantarjian, H., Gutterman, J. U. and Talpaz, M. (1991). Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Blood. 78:2400-2406.
Wu, X., Ahn, E. Y., McKenna, M. A., Yeo, H. and McDonald, J. M. (2005). Fas binding to calmodulin regulates apoptosis in osteoclasts. J. Biol. Chem. 280:29964-26670.
Yang, X. B., Webb, D., Blaker, J., Boccaccini, A.R., Maquet, V., Cooper, C. and Oreffo, R. O. (2006). Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem. Biophys. Res. Commun. 342:1098-1107.
Zhong, D., Pal, S. K., Wan, C. and Zewail, A.H. (2001). Femtosecond dynamics of a drug-protein complex: daunomycin with Apo riboflavin-binding protein. 98:11873-11878.
|
|---|
